Telratolimod
Telratolimod (MEDI9197) is a synthetic small molecule agonist of Toll-like receptors 7 and 8 (TLR7/8) developed for oncology research. Its antitumor activity, which involves stimulating innate immune responses, has been investigated in preclinical in vitro and in vivo studies for potential cancer immunotherapy applications.
Product Specifications
CAS Number
1359993-59-1
Product Name Alternative
Telratolimod, TLR7, TLR8, TLR7/8, TLR, Toll-like Receptor (TLR), MEDI9197, MEDI-9197, MEDI 9197, Inhibitor, inhibit, 3M 052, 3M052, 3M-052
Field of Research
Immunology & Inflammation
Purity
98.61% (May vary between batches)
Solubility
Ethanol:12.5 mg/mL (21.05 mM) ; DMSO:1.8 mg/mL (3.03 mM)
Smiles
CCCCCCCCCCCCCCCCCC (=O) NCCCCOn1c (CCCC) nc2c (N) nc3ccccc3c12
Molecular Formula
C36H59N5O2
Molecular Weight
593.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2548051 100 µL
Caspase-12 Rabbit Polyclonal Antibody (PerCP-Cy5.5)
Sign In for Pricing
View Details 
MBS6296469-01 0.2 mL
ERF3B, ID (GSPT2, ERF3B, Eukaryotic peptide chain release factor GTP-binding subunit ERF3B, G1 to S phase transition protein 2 homolog) (PE)
Sign In for Pricing
View Details MBS6296469-02 5x 0.2 mL
ERF3B, ID (GSPT2, ERF3B, Eukaryotic peptide chain release factor GTP-binding subunit ERF3B, G1 to S phase transition protein 2 homolog) (PE)
Sign In for Pricing
View Details